Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2026-01-21 @ 1:20 AM
Study NCT ID:
NCT00764634
Status:
COMPLETED
Last Update Posted:
2011-12-02
First Post:
2008-09-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
Sponsor:
DynPort Vaccine Company LLC, A GDIT Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
rBV A/B-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None